BioNTech SE plans to expand its global footprint to Asia with the establishment of its Regional Headquarters in Singapore. The company also plans to establish a fully integrated mRNA manufacturing facility in Singapore with support from the Singapore Economic Development Board. The new facility will provide regional and global supply capacity of BioNTech’s pipeline of mRNA-based product candidates, as well as a rapid response production capability for south east Asia to address potential pandemi...